Secondary use of data study characterizing Kesimpta (ofatumumab) onboarding and utilization in RMS patients using MSGo, with a non-interventional primary use of data sub-study comparing Patient Reported Outcomes relative to Clinical Outcomes (EAFToS) (NCT05090033)

COMB157GAU01

This trial is No longer recruiting
Registration number NCT05090033

Program & service

This trial is being run with the Brain service, and as part of the MSNI program.

Trial phase

Phase 1

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

Associate Professor Anneke Van Der Walt

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.